Durda Vukicevic, MD
MD
Institute of Public Health, Medical Decision Making and Health Technology Assessment, Department of Public Health and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.T., Austria
6060
Hall in Tirol
Austria
6060
Papers:
CHRONIC MYELOID LEUKEMIA TREATMENT: STARTING WITH A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB?